Urinary F2-Isoprostanes and Metabolic Markers of Fat Oxidation

Urinary F2-Isoprostanes and Metabolic Markers of Fat Oxidation

Metabolomic studies of increased fat oxidation showed increase in circulating acylcarnitines C2, C8, C10, and C12 and decrease in C3, C4, and C5. We hypothesize that urinary F2-isoprostanes reflect intensity of fatty acid oxidation and are associated with circulating C2, C8, C10, and C12 directly an...

Full description

Bibliographic Details
Main Authors:	Dora Il’yasova, Lynne E. Wagenknecht, Ivan Spasojevic, Steven Watkins, Donald Bowden, Frances Wang, Ralph B. D’Agostino
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Oxidative Medicine and Cellular Longevity
Online Access:	http://dx.doi.org/10.1155/2015/729191

Similar Items

African Ancestry Gradient Is Associated with Lower Systemic F2-Isoprostane Levels
by: Francis Annor, et al.
Published: (2017-01-01)

8-isoprostane as the main marker of oxidative stress
by: N. M. Herasymchuk
Published: (2018-12-01)

Isoprostanes
by: L. Jackson Roberts, II, et al.
Published: (2009-01-01)

Editorial: Using Cells in Epidemiological Studies to Characterize Individual Response to Environmental Hazards
by: Dora Il'yasova, et al.
Published: (2019-10-01)

Analysis of Fâ†2-isoprostanes as markers of lipid peroxidation
by: Gopaul, Nitin Kumar
Published: (1997)

Impact of Ramadan Intermittent Fasting on Oxidative Stress Measured by Urinary 15-F2t-Isoprostane
by: Mo'ez Al-Islam Ezzat Faris, et al.
Published: (2012-01-01)

Oxidative Status and Hypertension: An Examination of the Prospective Association Between Urinary F2-isoprostanes and Hypertension
by: Melton, Charles
Published: (2015)

Isoprostanes – A novel major group of oxidative stress markers
by: Marta Czerska, et al.
Published: (2016-04-01)

Is F-2-isoprostane a biological marker for the early onset of type 2 diabetes mellitus?
by: Chinna, K, et al.

Is F2 -isoprostane a biological marker for the early onset of type 2 diabetes mellitus?
by: Chinna, K., et al.

Diet and Oxidative Status. The Dietary Pattern and Urinary 8-Isoprostane in Healthy Spanish Women
by: Nuria Ruiz, et al.
Published: (2019-08-01)

Impaired renal function and increased urinary isoprostane excretion in Ghanaian women with pre-eclampsia
by: Tetteh PW, et al.
Published: (2013-06-01)

Platelet function and Isoprostane biology. Should Isoprostanes be the newest member of the Orphan-ligand family?
by: Khasawneh Fadi T, et al.
Published: (2010-04-01)

Obese rats exhibit high levels of fat necrosis and isoprostanes in taurocholate-induced acute pancreatitis.
by: Javier Pereda, et al.
Published: (2012-01-01)

Erythrocyte membrane isoprostane: a new tissue marker for in vivo oxidative stress assessment.
Published: (2005)

HDL is the major lipoprotein carrier of plasma F2-isoprostanes
by: Julie M. Proudfoot, et al.
Published: (2009-04-01)

Collision-induced dissociation of F2-isoprostane-containing phospholipids
by: KA Kayganich-Harrison, et al.
Published: (1993-07-01)

Elevated levels of urinary 8-hydroxy-2′-deoxyguanosine and 8-isoprostane in esophageal squamous cell carcinoma
by: Mohammad-Hassan Khadem-Ansari, et al.
Published: (2011-01-01)

A Cell-Based Approach to Study the Associations Between Mitochondrial Health, Early Life Exposures, and Consequent Health Outcomes
by: Dora Il'yasova, et al.
Published: (2019-03-01)

The role of prostanoids and isoprostanes in airway inflammation
by: Clarke, Deborah Lee
Published: (2003)

Exhaled 8-isoprostane in childhood asthma
by: Bush Andrew, et al.
Published: (2005-07-01)

Control of matrix effects in the analysis of urinary F2-isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS
by: Bo Zhang, et al.
Published: (2007-03-01)

Exhaled 8-isoprostane as a prognostic marker in sarcoidosis. A short term follow-up
by: Marczak Jerzy, et al.
Published: (2010-04-01)

Monitoring changes in serum 8-isoprostane concentration as a possible marker of oxidative stress in pregnancy
by: Jasmina Gradaščević Gubaljević, et al.
Published: (2013-12-01)

Evidence that the E2-isoprostane, 15-E2t-isoprostane (8-iso-prostaglandin E2) is formed in vivo
by: Jason D. Morrow, et al.
Published: (1998-08-01)

Sociodemographic and Lifestyle Determinants of Plasma Oxidative Stress Markers 8-OHdG and F2-Isoprostanes and Associations with Metabolic Syndrome
by: Catherine N. Black, et al.
Published: (2016-01-01)

Association Between Melanoma And Glioma: An Observaitonal Study In A Random Sample Of The Taiwanese Populaiton
by: Chu, Yeong Ruey, et al.
Published: (2017)

Isoprostanes in Veterinary Medicine: Beyond a Biomarker
by: Ashley K. Putman, et al.
Published: (2021-01-01)

Serum 8-isoprostane increased in pre-eclampsia
by: Besari Adi Pramono, et al.
Published: (2012-04-01)

Serum 8-isoprostane increased in pre-eclampsia
by: Besari Adi Pramono, et al.
Published: (2015-12-01)

The pathophysiology of the Fâ†2-isoprostanes with the coronary circulation
by: Kromer, Brendan Michael
Published: (1998)

Effects of Six Functional SNPs on the Urinary 8-Isoprostane Level in a General Japanese Population; Shimane COHRE Study
by: Yoji Suyama, et al.
Published: (2011-01-01)

Saliva Levels of 15-F-Isoprostane as Biomarker of Lipid Peroxidation in Autistic Children
by: A. Karamouzi, et al.
Published: (2007-09-01)

Plasma F2-isoprostanes in healthy and diabetic subjects: analysis by mass spectrometry.
Published: (2000)

Increasing Incidence of Liposarcoma: A Population-Based Study of National Surveillance Databases, 2001–2016
by: Suzanne Bock, et al.
Published: (2020-04-01)

Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
by: Caterina Coviello, et al.
Published: (2020-09-01)

Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease
by: Siedlak Sandra L, et al.
Published: (2007-01-01)

Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases
by: Elżbieta Miller, et al.
Published: (2014-01-01)

Can isoprostanes be used to predict survival in horses with colic?
by: Noschka, Erik
Published: (2014)

A protocol for quantifying lipid peroxidation in cellular systems by F2-isoprostane analysis.
by: Christiaan F Labuschagne, et al.
Published: (2013-01-01)